Innovation is at the heart of our R&D. Our researchers and scientists are striving to bring scientific breakthroughs from the lab to patients worldwide.
Takeda R&D continues its transformation, driving our patient-centric approach and commitment to deliver innovation.
We innovate with focus on three therapeutic areas- oncology, gastroenterology (GI), and the central nervous system (CNS). We also leverage our world-class capabilities to develop vaccines to address critical public health threats using novel development platforms, and collaborate with leading partners.
Shonan Health Innovation Park Concept is Japan's first pharma-led openly innovative ecosystem built on pharmaceutical know-how where industry, government, and academia come together to incubate and accelerate the translation of cutting-edge life science into impactful health solutions for patients in Japan and globally.
The Innovators in Science Award, proudly sponsored by Takeda and administered by the New York Academy of Sciences, was established in November, 2016. It recognizes a promising Early Career Scientist and an outstanding Senior Scientist’s contributions to science in the therapeutic areas of Neuroscience, Gastroenterology, Regenerative Medicine, and Oncology. The award is intended to support their commitment to innovative research.
Two prizes of US$200,000 are awarded each year, in a specific therapeutic area: one to an Early Career Scientist and the other to a well-established Senior Scientist from around the world who have distinguished themselves for their creative thinking and impact of research.